Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0000947871-23-000452

10% owner sold 67,537 shares at an average $1.80 ($121,357)

From the SEC's structured data for this filing

Trades in this filing

ORBIMED ADVISORS LLC · 10% owner

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-10 Sale : show line 1 in the form −2,584 $1.79 $4,625 185,910 I
2023-04-10 Sale : show line 2 in the form −13,899 $1.79 $24,879 1,000,187 I
2023-04-10 Sale : show line 3 in the form −34,745 $1.79 $62,194 2,500,582 I
2023-04-11 Sale : show line 4 in the form −703 $1.82 $1,279 183,326 I
2023-04-11 Sale : show line 5 in the form −3,784 $1.82 $6,887 986,288 I
2023-04-11 Sale : show line 6 in the form −9,459 $1.82 $17,215 2,465,837 I
2023-04-12 Sale : show line 7 in the form −119 $1.81 $215 183,207 I
2023-04-12 Sale : show line 8 in the form −641 $1.81 $1,160 985,647 I
2023-04-12 Sale : show line 9 in the form −1,603 $1.81 $2,901 2,464,234 I
Open-market sales · 67,537 sh · avg $1.80 · $121,357
Loading xslF345X04/ownership.xml…